Take a look at the article

Outcomes in Four Children with Persistent, Recurrent, and Progressive Gangliogliomas Treated in Phase II Studies with Antineoplastons A10 and AS2-1

Burzynski Stanislaw, Burzynski Gregory, Janicki Tomasz, Beenken Samuel